Prudential Financial
CTSO icon

Prudential Financial’s Cytosorbents Corp CTSO Stock Holding History

Prudential Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,800
Closed -$22.2K – 2357
2024
Q3 		$22.2K Buy
+14,800
New +$16.2K ﹤0.01% 2692

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Prudential Financial's CTSO Position: Q4 2024 in Review

Prudential Financial sold out of Cytosorbents Corp (CTSO) in Q4 2024, closing a stake of 14,800 shares — an estimated $22.2K sold.

Prudential Financial first reported a position in CTSO in Q3 2024 and held it in 1 quarter. The position peaked at $22.2K in Q3 2024. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.

  • Prudential Financial reported no remaining Cytosorbents Corp position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 14,800 Cytosorbents Corp shares in Q4 2024, an estimated $22.2K.
  • Prudential Financial first reported a position in Cytosorbents Corp in Q3 2024 and held it in 1 quarter.
  • Prudential Financial's Cytosorbents Corp position peaked at $22.2K in Q3 2024.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.